News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SFL to Present at the 8th Annual Conference of the Pharmaceutical Contract Management Group


6/7/2012 9:43:18 AM

June 07, 2012 -- SFL is pleased to announce that Dr Faiz Kermani, Senior Communication Manager, will be giving a presentation entitled “The Regulatory Framework for New Drug Innovation” at the 8th Annual Conference of the Pharmaceutical Contract Management Group.

This year’s PCMG meeting will be held on 13-15th June 2012, at the Sheraton Pine Cliffs Hotel, Portugal and will have the theme ‘Innovation in a changing market’. Faiz’s presentation will briefly summarize the role of key regulatory agencies and highlight examples of how the regulatory framework in different countries has influenced innovation. In addition, he will look at some of the proposed initiatives to further improve the regulatory framework and encourage R&D in the life sciences sector. The PCMG is the leading forum in Europe for the discussion and improvement of outsourcing issues and practices. The PCMG now has more than 120 members from a wide spectrum of organizations, across 11 countries, including traditional pharmaceutical, biotechnology, and virtual development companies.

“It is timely that this year’s PCMG meeting will focus on the theme of innovation,” commented Faiz.

“There is no doubt that regulators have a role to play in supporting new drug development. Currently, there are a number of initiatives underway to boost innovation that will involve regulators, industry and other stakeholders.”

Faiz is Senior Communications Manager at SFL. He is responsible for business development, marketing and communication. Previously, Faiz has worked in marketing and medical communications, pharmaceutical R&D, clinical trials, and pricing and reimbursement. Faiz has a PhD in Immunopharmacology from St. Thomas' Hospital, London and a First Class Honours degree in Pharmacology with Toxicology from King's College, London.

About SFL Regulatory Affairs & Scientific Communication Ltd:

SFL provides a holistic approach to lifecycle management of healthcare products. The company’s team of professionals have experience in Regulatory Affairs, Public Affairs, Legal Services and Medical Communications. We support our clients by offering personalized and comprehensive services. When combined, these services provide an integral oversight package for products from the bench to the marketplace at one consultancy.


Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES